Taken together with these results, peripheral T cell cytotoxicity reflects the cytotoxic activity of effector memory T cells and has the potential to predict the efficacy of anti-PD-1 therapy for NSCLC patients. The gene discussed is PDCD1; the disease is non-small cell lung carcinoma.